- Home
- WSBF vs AVIR Comparison
WSBF vs AVIR Comparison
Compare WSBF & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WSBF | AVIR |
|---|---|---|
| Founded | 1921 | 2012 |
| Country | United States | United States |
| Employees | N/A | 55 |
| Industry | Savings Institutions | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 325.5M | 450.9M |
| IPO Year | 2013 | 2020 |
Fundamental Metrics
Financial Performance| Metric | WSBF | AVIR |
|---|---|---|
| Price | $17.76 | $5.72 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | 47.1K | ★ 574.1K |
| Earning Date | 04-21-2026 | 03-05-2026 |
| Dividend Yield | ★ 3.36% | N/A |
| EPS Growth | ★ 46.53 | 3.00 |
| EPS | ★ 1.48 | N/A |
| Revenue | N/A | ★ $351,367,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $12.06 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.61 | $2.46 |
| 52 Week High | $18.88 | $6.45 |
Technical Indicators
Market Signals| Indicator | WSBF | AVIR |
|---|---|---|
| Relative Strength Index (RSI) | 52.37 | 60.65 |
| Support Level | $17.48 | $3.33 |
| Resistance Level | $18.61 | $6.45 |
| Average True Range (ATR) | 0.53 | 0.34 |
| MACD | 0.00 | -0.03 |
| Stochastic Oscillator | 60.91 | 58.86 |
Price Performance
Historical ComparisonAbout WSBF Waterstone Financial Inc. (MD)
Waterstone Financial Inc is a holding company. Through its subsidiaries, it operates in two reportable segments: Community Banking and Mortgage Banking. The Community Banking segment provides consumer and business banking products and services to customers, which include various types of loans, deposits, and personal investment services. The Mortgage Banking segment involves residential mortgage loans for the primary purpose of sale in the secondary market. The majority of its revenue comes from the Community Banking segment.
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.